LH
$326.89
-4.61
(-1.39%)
As of Sep 5, 2026, 8:21 AM EDT · cached
Price history
Labcorp (LH) is trading down at $326.89 (-1.39%) on NYSE/NASDAQ, as of the latest quote. It is a S&P 500 constituent in the Health Care sector.
About Labcorp
Labcorp Holdings Inc., operating under the brand name Labcorp, headquartered in Burlington, North Carolina, provides laboratory services used for diagnosis and healthcare decisions. It operates one of the largest clinical laboratory networks in the world and has operations in over 100 countries; although its operations are primarily in the U.S.
Recent News (19)
-
If you conducted Search Queries on Labcorp's website from May 1, 2021 to April 1, 2026, a class action settlement may affect you GREENSBORO, N.C., Sept. 4, 2026 /PRNewswire/ -- WHAT IS THIS ABOUT? Plaintiffs allege that Labcorp violated California and Pennsylvania wiretapping laws by facilitating, through third-party tracking t…
-
Labcorp Launches Next Generation of Labcorp Global Trial Connect™ to Help Sponsors and Investigator Sites Navigate Clinical Trial Complexity Enhanced digital experience designed to improve visibility, simplify workflows and support faster decision-making BURLINGTON, N.C., Aug. 31, 2026 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of…
-
Labcorp to Speak at the Morgan Stanley 24th Annual Global Healthcare Conference BURLINGTON, N.C., Aug. 28, 2026 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today that members of the executive management team w…
-
Labcorp Holdings Inc stock hits all-time high at 339.78 USD
Labcorp Holdings Inc stock hits all-time high at 339.78 USD
-
Are Wall Street Analysts Bullish on Labcorp Holdings Stock?
Are Wall Street Analysts Bullish on Labcorp Holdings Stock?
-
Labcorp to Offer First FDA-Cleared Blood Test to Detect Alzheimer's Disease Pathology in Both Primary and Specialty Care Settings Elecsys® pTau-217 is the first and only FDA-cleared single-biomarker blood test to both rule in and rule out amyloid pathology across specialty and primary care settings Measures phosphorylated Tau 21…
-
-
-
Labcorp announces executive leadership changes effective in September
Labcorp announces executive leadership changes effective in September
-
Labcorp CEO Adam Schechter Sells 4,669 Shares for $1.5 Million
Labcorp CEO Adam Schechter Sells 4,669 Shares for $1.5 Million
-
Labcorp president & CEO Adam Schechter sells $1.5m in company stock
Labcorp president & CEO Adam Schechter sells $1.5m in company stock
-
-
Labcorp Launches FDA-Approved PTEN Companion Diagnostic for Prostate Cancer First FDA-approved IHC assay identifies patients who may be eligible for combination treatment with TRUQAP® (capivasertib) BURLINGTON, N.C., Aug. 4, 2026 /PRNewswire/ -- Labcorp (NYSE: LH), a global l…
-
-
-
Labcorp raises annual profit forecast on strong testing demand Labcorp raises annual profit forecast on strong testing demand
-
-
Labcorp launches genetic health panel for consumers
Labcorp launches genetic health panel for consumers
-
More Health Care stocks
- CI Cigna
- CVS CVS Health
- DGX Quest Diagnostics
- DVA DaVita
- A Agilent Technologies
- ABBV AbbVie
- ABT Abbott Laboratories
- ALGN Align Technology